Navigation Links
Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin
Date:5/15/2009

Study Findings Confirm Glycerin Accelerates the Healing Process

in Damaged Tissue and Cells

MANDEVILLE, La., May 15 /PRNewswire/ -- Today, a leading expert in the field of non-surgical skin rejuvenation announced results from a study demonstrating that glycerin helps to speed up the healing process of damaged tissue and cells, resulting in less bruising and skin discoloration.

In a double-blinded, placebo-controlled clinical study of a glycerin-based bruise-reaction product, 65 percent of the patients who experienced bruising after filler injection procedures saw a reduction in the severity and duration of bruising with a single post-procedural application of Bruise Relief(TM) serum versus a placebo. The product was found to reduce the appearance of bruising with no reported side effects.

"Glycerin, as an active ingredient in Bruise Relief(TM), helps with the rejuvenation process of the skin," said Dr. Mary P. Lupo, dermatologist and non-surgical skin rejuvenation expert. "The most common treatment-related complication from filler injections is bruising. I have seen a significant decrease in bruising after treatments with an application of Bruise Relief(TM). Post-procedural Botox and leg vein injections (sclerotherapy) may also benefit from this single post-procedural application."

Glycerin, a humectant, attracts water and helps lubricate and hydrate the skin's cells. It is a thick, water-soluble liquid. Bruises occur when capillary blood vessels break and blood and fluids pool underneath the skin. Glycerin's hydrating properties enable the body to seal off the broken capillaries and blood vessels caused by trauma to the skin and help prevent the pooling of blood and fluids.

Bruise Relief(TM), available in a gel or serum formulation, also contains vitamins, nutrients and antioxidants and is non-toxic and safe for all ages and skin types. Bruise Relief (TM) gel is available nationwide at all CVS stores as well as at Jewel/Osco, Albertsons, Acme, Shaw's and other fine pharmacies across the country.

"Bruise Relief(TM) has been in my family for nearly five generations," said Barbara Cranner, executive vice president of Dr. Holmquist Healthcare, LLC. "We developed the product for the mass market with my stepfather, Dr. Nelson Holmquist, and we are thrilled to share an old family recipe with the world."

About Dr. Holmquist Healthcare, LLC

Dr. Holmquist Healthcare, LLC is a family- and majority-woman-owned and operated company. Headquartered in Mandeville, Louisiana, the company is dedicated to the revitalization of New Orleans, and manufactures the company's product lines at local plants. Dr. Holmquist Healthcare's product line currently features Bruise Relief(TM), a topical skin care product in a gel and serum formulation designed to eliminate the appearance of bruising and skin discoloration. Learn more about Dr. Holmquist Healthcare and its products at http://www.bruiserelief.com.

CONTACT: Holly Campbell, Levick Strategic Communications, +1-202-973-1337, hcampbell@levick.com


'/>"/>
SOURCE Dr. Holmquist Healthcare, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
3. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
4. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
5. Derma Sciences MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
8. Clinically Proven Treatment Offers Help to Rosacea Sufferers
9. Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... The ... care facility – Avamere Transitional Care of Puget Sound ; located at ... health care center will provide patients recovering from illness or injury with intensive ...
(Date:12/5/2016)... VA (PRWEB) , ... December 05, 2016 , ... ... today announced it has been featured in SuperbCrew magazine, a leading online tech ... tech world. This interview, now featured on SuperbCrew.com, explores the state of enterprise ...
(Date:12/5/2016)... ... ... Researchers at Johns Hopkins All Children’s Hospital want to learn more about ... of three years, researchers will study concussions and changes in brain function by monitoring ... sensors, will track the location and force of the hit. The sensors store data ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
Breaking Medicine News(10 mins):